COR
Price
$281.67
Change
+$0.19 (+0.07%)
Updated
Jun 12 closing price
Capitalization
54.8B
52 days until earnings call
Intraday BUY SELL Signals
HSIC
Price
$81.25
Change
+$1.03 (+1.28%)
Updated
Jun 12 closing price
Capitalization
9.26B
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COR vs HSIC

Header iconCOR vs HSIC Comparison
Open Charts COR vs HSICBanner chart's image
COR vs HSIC Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COR vs. HSIC commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COR is a Buy and HSIC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (COR: $281.67 vs. HSIC: $81.25)
Brand notoriety: COR and HSIC are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: COR: 59% vs. HSIC: 76%
Market capitalization -- COR: $54.8B vs. HSIC: $9.26B
COR [@Medical Distributors] is valued at $54.8B. HSIC’s [@Medical Distributors] market capitalization is $9.26B. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.25B to $0. The average market capitalization across the [@Medical Distributors] industry is $17.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COR’s FA Score shows that 1 FA rating(s) are green whileHSIC’s FA Score has 1 green FA rating(s).

  • COR’s FA Score: 1 green, 4 red.
  • HSIC’s FA Score: 1 green, 4 red.
According to our system of comparison, both COR and HSIC are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COR’s TA Score shows that 4 TA indicator(s) are bullish while HSIC’s TA Score has 6 bullish TA indicator(s).

  • COR’s TA Score: 4 bullish, 4 bearish.
  • HSIC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, COR is a better buy in the short-term than HSIC.

Price Growth

COR (@Medical Distributors) experienced а +2.41% price change this week, while HSIC (@Medical Distributors) price change was +4.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.12%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was -6.17%.

Reported Earning Dates

COR is expected to report earnings on Aug 05, 2026.

HSIC is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Medical Distributors (+1.12% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($54.8B) has a higher market cap than HSIC($9.26B). HSIC has higher P/E ratio than COR: HSIC (24.55) vs COR (21.58). HSIC YTD gains are higher at: 7.502 vs. COR (-16.269). COR has higher annual earnings (EBITDA): 5.03B vs. HSIC (981M). COR has more cash in the bank: 2.18B vs. HSIC (138M). HSIC has less debt than COR: HSIC (3.75B) vs COR (12.4B). COR has higher revenues than HSIC: COR (329B) vs HSIC (13.4B).
CORHSICCOR / HSIC
Capitalization54.8B9.26B592%
EBITDA5.03B981M513%
Gain YTD-16.2697.502-217%
P/E Ratio21.5824.5588%
Revenue329B13.4B2,455%
Total Cash2.18B138M1,577%
Total Debt12.4B3.75B331%
FUNDAMENTALS RATINGS
COR vs HSIC: Fundamental Ratings
COR
HSIC
OUTLOOK RATING
1..100
3537
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
3597
SMR RATING
1..100
1166
PRICE GROWTH RATING
1..100
6024
P/E GROWTH RATING
1..100
8742
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COR's Valuation (60) in the Real Estate Investment Trusts industry is in the same range as HSIC (64) in the Medical Distributors industry. This means that COR’s stock grew similarly to HSIC’s over the last 12 months.

COR's Profit vs Risk Rating (35) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HSIC (97) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than HSIC’s over the last 12 months.

COR's SMR Rating (11) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HSIC (66) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than HSIC’s over the last 12 months.

HSIC's Price Growth Rating (24) in the Medical Distributors industry is somewhat better than the same rating for COR (60) in the Real Estate Investment Trusts industry. This means that HSIC’s stock grew somewhat faster than COR’s over the last 12 months.

HSIC's P/E Growth Rating (42) in the Medical Distributors industry is somewhat better than the same rating for COR (87) in the Real Estate Investment Trusts industry. This means that HSIC’s stock grew somewhat faster than COR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORHSIC
RSI
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
63%
Momentum
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
48%
MACD
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
45%
Advances
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
51%
Declines
ODDS (%)
Bearish Trend 19 days ago
42%
Bearish Trend 12 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
COR
Daily Signal:
Gain/Loss:
HSIC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALSN117.351.83
+1.58%
Allison Transmission Holdings
ABLV1.10N/A
N/A
Able View Global
TACOU10.75N/A
N/A
Berto Acquisition Corp
WENN10.28N/A
N/A
Wen Acquisition Corp
CTS66.13-1.75
-2.58%
CTS Corp

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and MCK have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and MCK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
+1.28%
MCK - HSIC
22%
Poorly correlated
-0.40%
CAH - HSIC
18%
Poorly correlated
+1.22%
ACH - HSIC
12%
Poorly correlated
+3.74%
COR - HSIC
8%
Poorly correlated
+0.07%
COSM - HSIC
5%
Poorly correlated
+1.94%
More